Integration of blood and brain RNA expression data from ADNI and AMP-AD indicated that CPT1A was involved in the regulation of acylcarnitines and amino acids in AD, and gene co-expression network analysis leveraging AMP-AD brain RNA-seq data suggested the CPT1A-centered subnetwork was associated with neuronal system [54]. This evidence concerns the gene CPT1A and Alzheimer disease.